FEMARA (letrozole)
AROMATASE INHIBITORS·EARLY BREAST CANCER HORMONE RECEPTOR POSITIVE AND POSTMENOPAUSAL·+2
Novartis Pharmaceuticals
Indication
Hormone receptor positive postmenopausal advanced breast cancer
Hormone receptor-positive postmenopausal advanced breast cancer refers to locally advanced or metastatic malignancy arising from breast tissue in females who have experienced the permanent cessation of ovarian function. Read more about Hormone receptor positive postmenopausal advanced breast cancer
73 drugs 56 manufacturers
Drugs that treat it
Common Hormone receptor positive postmenopausal advanced breast cancer therapies.
FASLODEX (fulvestrant)
ANTIESTROGEN·HORMONE RECEPTOR POSITIVE POSTMENOPAUSAL ADVANCED BREAST CANCER·+1
AstraZeneca Pharmaceuticals
LETROZOLE
AROMATASE INHIBITORS·EARLY BREAST CANCER HORMONE RECEPTOR POSITIVE AND POSTMENOPAUSAL·+2
ACCORD HEALTHCA
ANASTROZOLE
AROMATASE INHIBITORS·METASTATIC BREAST CARCINOMA·+2
Mylan Pharmaceuticals
ANASTROZOLE
AROMATASE INHIBITORS·METASTATIC BREAST CARCINOMA·+2
DR.REDDY'S LAB
ANASTROZOLE
AROMATASE INHIBITORS·METASTATIC BREAST CARCINOMA·+2
SUN PHARMACEUTI
ANASTROZOLE
AROMATASE INHIBITORS·METASTATIC BREAST CARCINOMA·+2
ZYDUS PHARMACEU
ANASTROZOLE
METASTATIC BREAST CARCINOMA·+2
PACK PHARMACEUT
ANASTROZOLE
AROMATASE INHIBITORS·METASTATIC BREAST CARCINOMA·+2
ACCORD HEALTHCA
Filter & compare in the drug finder →Opens the drug finder with Hormone receptor positive postmenopausal advanced breast cancer preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHormone receptor-positive postmenopausal advanced breast cancer refers to locally advanced or metastatic malignancy arising from breast tissue in females who have experienced the permanent cessation of ovarian function.
Pathophysiologically, the tumor cells express estrogen receptors, progesterone receptors, or both, rendering disease proliferation dependent on estrogenic signaling pathways derived primarily from peripheral aromatization in postmenopausal biology.
The advanced stage signifies that the neoplasm is unresectable, involves extensive regional lymph nodes or chest wall structures, or has disseminated hematogenously to distant metastatic sites such as bone, liver, lungs, or brain.
- cancer.gov
Hormone receptor-positive postmenopausal advanced breast cancer refers to locally advanced or metastatic malignancy arising from breast tissue in females who have experienced the permanent cessation of ovarian function
- cancernetwork.com
Hormone receptor-positive postmenopausal advanced breast cancer refers to locally advanced or metastatic malignancy arising from breast tissue in females who have experienced the permanent cessation of ovarian function Pathophysiologically, the tumor cells express estrogen receptors, progesterone receptors, or both, rendering disease proliferation dependent on estrogenic signaling pathways derived primarily from peripheral aromatization in postmenopausal biology The advanced stage signifies that...
- lbbc.org
Hormone receptor-positive postmenopausal advanced breast cancer refers to locally advanced or metastatic malignancy arising from breast tissue in females who have experienced the permanent cessation of ovarian function
- cancer.org
Pathophysiologically, the tumor cells express estrogen receptors, progesterone receptors, or both, rendering disease proliferation dependent on estrogenic signaling pathways derived primarily from peripheral aromatization in postmenopausal biology
- nih.gov
Pathophysiologically, the tumor cells express estrogen receptors, progesterone receptors, or both, rendering disease proliferation dependent on estrogenic signaling pathways derived primarily from peripheral aromatization in postmenopausal biology
Personalize your experience
Follow Hormone receptor positive postmenopausal advanced breast cancer and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.